Disease/Infection News

RSS

U.S. leaders, AIDS activists gather in Washington to discuss 'shared responsibility' in tackling disease

An article on the UNAIDS webpage reports on "a high-powered breakfast meeting that took place in Washington, D.C., on 18 April," which "brought together leaders in the response to AIDS with members of the United States Congress, the administration, the private sector and AIDS advocates to emphasize how the adoption of the 'shared responsibility' approach is translating joint efforts into real results."

23 Apr 2013

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

When a person contracts Lyme disease, quick diagnosis and treatment are essential to avoiding long term complications. But the diagnostic process may be delayed if a physician does not recognize a skin rash caused by Lyme disease because it does not have the bull's-eye appearance that is best known to physicians and the public.

23 Apr 2013

Global Fund working to fight malaria in Latin America

In the ONE blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes about how the Global Fund to Fight AIDS, Tuberculosis and Malaria is working to prevent malaria in Latin America.

23 Apr 2013

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.

23 Apr 2013

Merck, Bristol-Myers Squibb to evaluate daclatasvir and MK-5172 for treatment of HCV infection

Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.

23 Apr 2013

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Gold nanoparticles are tiny spherical particles made out of gold atoms with sizes on nanometre scale. This is around 1,000 times smaller than the thickness of human hair.

23 Apr 2013

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

When thousands of experimental biology researchers gather in Boston this weekend, many of them undoubtedly will be presenting work related to the hunt for the next generation of antibiotics and how to battle back existing and emerging superbugs.

22 Apr 2013

Vaginal infections can be treated and prevented using Cranberry-Active tablets

Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts.

22 Apr 2013

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 - and that drug was approved two and a half years ago.

22 Apr 2013

TEDMED conference speaker highlights key actions to stop pandemics

Some 2,000 health professionals and thought leaders from all sectors of society are attending TEDMED at the Kennedy Center [in Washington, D.C.,] this week for a series of talks [focusing on medical technology and health care], which are also being televised in more than 80 countries.

22 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

A gene therapy study focused on finding a cure for a rare congenital blinding disease has been recognized as one of the ten most outstanding clinical research projects of the year by the Clinical Research Forum (CRF).

22 Apr 2013

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

People lobbying for gun control may want to consider another culprit in the post-Newtown search for the answer to our unfathomable questions.

22 Apr 2013

Donors must 'seize this opportunity' to fully support the Global Fund

At a recent donor conference in Brussels, Belgium, "the Global Fund to Fight AIDS, Tuberculosis and Malaria presented a compelling case for funding the organization to not only tackle these diseases but also to accelerate gains against them.

22 Apr 2013

Genetic study defines link between primary sclerosing cholangitis and other autoimmune diseases

Researchers have newly associated nine genetic regions with a rare autoimmune disease of the liver known as primary sclerosing cholangitis (PSC). This brings the total number of genetic regions associated with the disease to 16.

22 Apr 2013

Researchers decipher the underlying mechanism of antiviral drug

A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never approved for clinical use.

22 Apr 2013

Study: Use of anti-TNF therapies in RA patients does not increase risk of herpes zoster

Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment regimens, according to research from the University of Alabama at Birmingham (UAB) and the Oregon Health and Science University. The findings appeared in the March 6, 2013, issue of the Journal of the American Medical Association (JAMA).

22 Apr 2013

Vaccine development expensive but worthy of investment from Congress

During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines, and the collaborative efforts of the [CDC], [the WHO], national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases.

22 Apr 2013

Study confirms effectiveness of UV-C-emitting device in combating pathogens in hospital environment

A recent study funded by Centers for Disease Control and Prevention Epicenters Program and published in Infection Control and Hospital Epidemiology ( Deverick H. Anderson , M.D., MPH et al., 2013) supports and expands on previously published studies confirming the effectiveness of an automated UV-C-emitting device to combat the pathogens Clostridium difficile (C. diff.), vancomycin-resistant enterococci (VRE) and Acinetobacter spp. – some of the common culprits of health care-associated infections drawing increased attention for hospitals across the country.

20 Apr 2013

State Department hosts online discussions on foreign aid, HIV/AIDS

Richard Buangan, director of digital engagement at the U.S. State Department, notes in the agency's "DipNote" blog that Secretary of State John Kerry will participate in a Google+ hangout on Friday, April 19, at 1:15 pm EDT.

20 Apr 2013

Disease/Infection News

U.S. leaders, AIDS activists gather in Washington to discuss 'shared responsibility' in tackling disease

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

Global Fund working to fight malaria in Latin America

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Merck, Bristol-Myers Squibb to evaluate daclatasvir and MK-5172 for treatment of HCV infection

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

Vaginal infections can be treated and prevented using Cranberry-Active tablets

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

TEDMED conference speaker highlights key actions to stop pandemics

Edible malarial vaccine may work against other viral and bacterial infections

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

Donors must 'seize this opportunity' to fully support the Global Fund

Genetic study defines link between primary sclerosing cholangitis and other autoimmune diseases

Researchers decipher the underlying mechanism of antiviral drug

Study: Use of anti-TNF therapies in RA patients does not increase risk of herpes zoster

Vaccine development expensive but worthy of investment from Congress

Study confirms effectiveness of UV-C-emitting device in combating pathogens in hospital environment

State Department hosts online discussions on foreign aid, HIV/AIDS

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News